KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

Lucknow: King George’s Medical University (KGMU) will file an FIR against four employees after a probe found alleged irregularities worth around Rs 2.5 crore in medicines procurement under the Asadhya Yojana. The scheme provides free treatment to poor patients with chronic diseases.

A five-member inquiry committee found irregularities in the urology department and recommended action against one regular pharmacist and three contractual employees.

KGMU spokesperson Prof KK Singh said the FIR will be registered on Tuesday.

The matter came to light after officials noticed a sharp rise in medicine expenditure, which jumped from Rs 10 lakh a month to Rs 40 lakh in Feb and Rs 45 lakh in March, triggering an audit that revealed discrepancies.
Each injection costs between Rs 8,000 and Rs 10,000.

It also found cases where medicines were shown as administered without the patient being admitted. This raised suspicion of misuse of govt funds.

The inquiry flagged violations of drug management procedures. A contractual employee handled the ordering and receipt of medicines, violating the rule that assigns authorised nursing staff to perform this task.

The committee suspects that these medicines may have been diverted and is examining where the drugs were disposed of. The panel recommended criminal proceedings against the four employees.

KGMU stopped payments for medicines under scrutiny and constituted a committee on the directions of vice-chancellor Prof Soniya Nityanand.

The panel examined patient records, distribution registers and payment data. It found that medicines were shown as consumed beyond the prescribed dosage.

In several cases, an injectable drug meant to be administered once every six months was shown as administered four to five times in a month.

Related Posts

Centre bans fixed-dose combination for Common Cold in children below four

The ministry said the use of “Chlorpheniramine Maleate and Phenylephrine Hydrochloride” drug combination in children below four years could pose health risks, while their safer alternatives are available in the…

New research study proposes a unifying theory for Alzheimer’s disease and other neurodegenerative diseases

A new peer-reviewed paper by neuroscientist Dale E. Bredesen proposes a unifying framework that could fundamentally change how researchers understand Alzheimer’s disease and other neurodegenerative disorders. Published on August 11…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Centre bans fixed-dose combination for Common Cold in children below four

Centre bans fixed-dose combination for Common Cold in children below four

New research study proposes a unifying theory for Alzheimer’s disease and other neurodegenerative diseases

New research study proposes a unifying theory for Alzheimer’s disease and other neurodegenerative diseases

Brain organoid maturation is driven by a lifelike developmental clock: Study

Brain organoid maturation is driven by a lifelike developmental clock: Study

Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses